Navigation Links
Jury Awards $5.25 Million Malpractice Verdict Against Fort Worth Doctor
Date:12/6/2007

Physician Admitted Taking 'Unacceptable Risk' With Patient

FORT WORTH, Texas, Dec. 6 /PRNewswire/ -- A Tarrant County jury has awarded $5.25 million to the family of a 75-year-old Fort Worth man who died after his physician failed to properly diagnose his symptoms.

Jurors deliberated about six hours over two days before issuing their verdict on Tuesday in the 236th District Court of Judge Thomas W. Lowe III. The jury found that Dr. Paul J. Goldman of Fort Worth missed significant warning signs in treating Charles R. Dunning when he came to Dr. Goldman's office in July 2003.

The court heard testimony that Mr. Dunning, who had been previously treated for a blood clot and wore compression stockings as a preventive measure, complained to Dr. Goldman of swelling in his right foot. He also told the doctor that he felt weak and had pain in his leg.

Despite Mr. Dunning's history of a previous blood clot, the doctor spent only 10 minutes with him and did not remove the compression stockings during the examination. Instead, Dr. Goldman scheduled a sonogram for the following day. Following the sonogram, Mr. Dunning returned to Dr. Goldman's office complaining of a back problem. While in the waiting room, Mr. Dunning collapsed and died of a massive pulmonary embolism.

Attorney Michael G. Guajardo, an attorney in Dallas' The Law Offices of Frank L. Branson, told jurors that Mr. Dunning exhibited classic symptoms of a blood clot that should have spurred the physician to order immediate testing.

"This was a heartbreaking case for those who loved Mr. Dunning," says Mr. Guajardo, who represented Mr. Dunning's wife and three adult children. "It's hard for them because his death was unnecessary. Mr. Dunning would be here today if proper procedures had been followed."

In court testimony, Dr. Goldman acknowledged that he had taken an "unacceptable risk" by delaying additional tests despite his knowledge of Mr. Dunning's medical history. He also stated that he had learned nothing from Mr. Dunning's death and would not act differently if presented with the same circumstances.

"When jurors hear testimony like that, they respond accordingly," Mr. Guajardo says. "Mr. Dunning's family is pleased with this verdict and hope it sends a strong message to the medical community that doctors need to listen to their patients."

The Law Offices of Frank L. Branson represents clients in cases involving complex product liability, catastrophic injury, commercial air crashes, professional negligence, and business torts. To learn more about the firm, please visit http://www.flbranson.com.

For more information about Mr. Dunning's case or to interview Mr. Guajardo, please contact Barry Pound at 214-559-4630 or by e-mail at barry@androvett.com.


'/>"/>
SOURCE Law Offices of Frank L. Branson
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Good Clinical Practice Journal Awards: Winners Announced
3. NIH awards $10.8M to Columbia to study connection between diabetes and heart disease
4. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
5. 2007 EURYI: 20 researchers to receive Nobel Prize-sized awards in Helsinki
6. HRET Awards Four Health Career Scholarships
7. Portico Systems Wins Three Awards in 30 Days
8. Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares
9. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
10. The Sisters of Charity Health System Awards Four Nursing Scholarships in Ohio and South Carolina
11. U.S. Labor Department Awards $10.1 Million for Safety and Health Training Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... compare student test score performance for the 2015-16 school year across Wisconsin’s public ... programs. Though it highlights important patterns in student test score performance, the report’s ...
(Date:4/25/2017)... ... 25, 2017 , ... As pharmaceutical companies are held to ... process innovation in drug formulation and manufacturing. CoreRx offers its clients more ... in support of their development and manufacturing goals. , The company was ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the ... or chronic problems, I focus on preventative care with all my patients to alleviate possible ... questions, always feel free to contact my office and my trained staff will assist you ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced that it will be participating ... Conference at the InterContinental Hotel in Boston, ... Biomet will present at 11:20 a.m. Eastern Time. ... accessed via Zimmer Biomet,s Investor Relations website at ...
(Date:4/20/2017)... -- Research and Markets has announced the addition of ... Expanding Injectables Market and Increasing Usage of Complex Biologics during the ... ... from USD 20 Billion in 2015 to around USD 26 Billion ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
Breaking Medicine Technology: